Related Experiment Videos
[Clinical study on tissue polypeptide antigen (TPA) as a tumor marker]
Gan No Rinsho. Japan Journal of Cancer Clinics
|March 1, 1984
Summary
Tissue polypeptide antigen (TPA) shows promise as a cancer biomarker. Elevated TPA levels were detected in various cancers, aiding in their identification and evaluation.
Area of Science:
- Oncology
- Biochemistry
- Clinical Diagnostics
Context:
- Accurate cancer staging and diagnosis are crucial for effective treatment.
- Existing tumor markers have limitations in sensitivity and specificity.
- Tissue polypeptide antigen (TPA) is a potential biomarker for various malignancies.
Purpose:
- To evaluate the diagnostic value of serum TPA assay in determining cancer stages.
- To compare TPA's efficacy against established tumor markers like CEA, AFP, beta2-microglobulin, ferritin, and elastase-1.
- To assess TPA levels in patients with various cancers and benign gastrointestinal diseases.
Summary:
- Serum TPA was analyzed in 33 gastric cancer, 7 colorectal cancer, and 15 hepatoma patients, alongside 169 benign gastrointestinal disease patients and 72 healthy volunteers.
- Positive TPA results ( > 200 u/l) were observed in 61% of gastric cancer, 71% of colorectal cancer, and 87% of hepatoma cases.
- Elevated TPA levels were also noted in active gastric ulcers and hepatitis, indicating potential for non-specific elevation. No significant correlation was found between TPA and other tumor markers.
Impact:
- TPA may serve as a valuable tool for identifying and evaluating cancer patients.
- Further research is warranted to elucidate TPA's role in cancer diagnostics and management.
- This study contributes to the ongoing search for improved cancer biomarkers.